Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate in allergic rhinitis and asthma
NCT01657097Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Feb 1997
- Primary completion
- Apr 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in allergic rhinitis (AR) comparing INCS with Placebo (2 arms). Primary endpoint: Serum Eosinophil Cationic Protein at 1 month. Started Feb 1997; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01657097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01657097.